• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NamePROGENSA PCA3 ASSAY
Classification Nameprostrate cancer genes nucleic acid amplification test system
ApplicantHOLOGIC, INC.
PMA NumberP100033
Supplement NumberS003
Date Received03/19/2015
Decision Date04/16/2015
Product Code
OYM[ Registered Establishments with OYM ]
Advisory Committee Pathology
Supplement Type30-day notice
Supplement Reason process change: manufacturing
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Manufacturing scale up of bulk enzyme reconstitution solution (p/n bs0421), by allowing bulking and filling from larger tanks (208l and 303l) and additionally, to extend the bulk hold time from 7 days up to 1 month to allow sufficient time for the solution to be used within manufacturing.
-
-